OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SOX11, CD70, and Treg cells configure the tumor immune microenvironment of aggressive mantle cell lymphoma
Patricia Balsas, Luis Veloza, Guillem Clot, et al.
Blood (2021) Vol. 138, Iss. 22, pp. 2202-2215
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Mantle cell lymphoma in 2022—A comprehensive update on molecular pathogenesis, risk stratification, clinical approach, and current and novel treatments
Preetesh Jain, Michael Wang
American Journal of Hematology (2022) Vol. 97, Iss. 5, pp. 638-656
Closed Access | Times Cited: 95

An Atlas of Cells in the Human Tonsil
Ramon Massoni-Badosa, Paula Soler-Vila, Sergio Aguilar-Fernández, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 29

SOX11 expression is restricted to EBV-negative Burkitt lymphoma and associates with molecular genetic features
Marta Sureda-Gómez, Ingram Iaccarino, Anna De Bolòs, et al.
Blood (2024) Vol. 144, Iss. 2, pp. 187-200
Open Access | Times Cited: 8

SOX on tumors, a comfort or a constraint?
Junqing Jiang, Yufei Wang, Mengyu Sun, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 7

A mechanistic, functional, and clinical perspective on targeting CD70 in cancer
Sandeep Kumar, Sowdhamini Mahendiran, Rakesh Sathish Nair, et al.
Cancer Letters (2024) Vol. 611, pp. 217428-217428
Open Access | Times Cited: 5

Beyond Bruton’s tyrosine kinase inhibitors in mantle cell lymphoma: bispecific antibodies, antibody–drug conjugates, CAR T-cells, and novel agents
Neeraj Jain, Mukesh Mamgain, Sayan Mullick Chowdhury, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 12

Regulatory T cells (Tregs) in lymphoid malignancies and the impact of novel therapies
Kamira Maharaj, Angimar Uriepero, Eva Sahakian, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 18

Tumor Microenvironment and Immunotherapy-Based Approaches in Mantle Cell Lymphoma
Khalil Saleh, Morgane Cheminant, David Chiron, et al.
Cancers (2022) Vol. 14, Iss. 13, pp. 3229-3229
Open Access | Times Cited: 17

Preclinical development and evaluation of nanobody-based CD70-specific CAR T cells for the treatment of acute myeloid leukemia
Jiali Cheng, Tong Ge, Xiaojian Zhu, et al.
Cancer Immunology Immunotherapy (2023) Vol. 72, Iss. 7, pp. 2331-2346
Open Access | Times Cited: 10

Role of the tumor microenvironment in CLL pathogenesis
Alexander F. vom Stein, Michael Hallek, Phuong‐Hien Nguyen
Seminars in Hematology (2023) Vol. 61, Iss. 3, pp. 142-154
Open Access | Times Cited: 10

Role of the SOX family in cancer immune evasion: Emerging player and promising therapeutic opportunities
Jin-ke Li, Yawen Xu, Ying Han, et al.
Medicine (2025) Vol. 104, Iss. 5, pp. e41393-e41393
Open Access

SOXs: Master architects of development and versatile emulators of oncogenesis
Saloni, Manisha Sachan, Rahul Johari, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189295-189295
Closed Access

NSD2 serves as a potential prognostic biomarker in mantle cell lymphoma
Yu Zhu, Binshen Ouyang, Xuan Wang, et al.
Laboratory Investigation (2025), pp. 104181-104181
Closed Access

Empowering macrophages: the cancer fighters within the tumour microenvironment in mantle cell lymphoma
Patrick Nylund, Anna Nikkarinen, Sara Ek, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3

SOX11/PRDX2 axis modulates redox homeostasis and chemoresistance in aggressive mantle cell lymphoma
Anna De Bolòs, Marta Sureda-Gómez, Maria Carreras-Caballé, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3

SOX11 is a novel binding partner and endogenous inhibitor of SAMHD1 ara-CTPase activity in mantle cell lymphoma
Mohammad Hamdy Abdelrazak Morsy, Ingrid Lilienthal, Martin Lord, et al.
Blood (2024) Vol. 143, Iss. 19, pp. 1953-1964
Open Access | Times Cited: 2

Integrated single cell analysis reveals co-evolution of malignant B cells and tumor micro-environment in transformed follicular lymphoma
Clémentine Sarkozy, Shaocheng Wu, Katsuyoshi Takata, et al.
Cancer Cell (2024) Vol. 42, Iss. 6, pp. 1003-1017.e6
Open Access | Times Cited: 2

Hypomethylation‐associated Sox11 upregulation promotes oncogenesis via the PI3K/AKT pathway in OLP‐associated OSCC
Yi Liu, Peilin Cao, Xiao Li, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 14
Open Access | Times Cited: 2

CAR-T Cells Shoot for New Targets: Novel Approaches to Boost Adoptive Cell Therapy for B Cell-Derived Malignancies
Katsiaryna Marhelava, Marta Krawczyk, Małgorzata Firczuk, et al.
Cells (2022) Vol. 11, Iss. 11, pp. 1804-1804
Open Access | Times Cited: 8

Systematic Investigation of the Multifaceted Role of SOX11 in Cancer
Qingqing Sun, Jun Du, Jie Dong, et al.
Cancers (2022) Vol. 14, Iss. 24, pp. 6103-6103
Open Access | Times Cited: 8

Immune-depleted tumor microenvironment is associated with poor outcomes and BTK inhibitor resistance in mantle cell lymphoma
Preetesh Jain, Krystle Nomie, Nikita Kotlov, et al.
Blood Cancer Journal (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 4

SOX11 as a prognostic biomarker linked to m6A modification and immune infiltration in renal clear cell carcinoma
Kaihong Wang, Xinpeng Chen, Yifu Liu, et al.
Translational Cancer Research (2024) Vol. 13, Iss. 7, pp. 3536-3555
Open Access | Times Cited: 1

Expression of soluble CD27 in extranodal natural killer/T-cell lymphoma, nasal type: potential as a biomarker for diagnosis and CD27/CD70-targeted therapy
Toshihiro Nagato, Hiroki Komatsuda, Ryusuke Hayashi, et al.
Cancer Immunology Immunotherapy (2023) Vol. 72, Iss. 7, pp. 2087-2098
Open Access | Times Cited: 3

Extrachromosomal circular DNA and their roles in cancer progression
Siqi Zheng, Yunong Li, Lin Wang, et al.
Genes & Diseases (2023) Vol. 12, Iss. 1, pp. 101202-101202
Open Access | Times Cited: 3

Page 1 - Next Page

Scroll to top